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Abstract
Introduction: Evidence	 suggests	 that	 toxic	 iron	 is	 involved	 in	 haemophilic	 joint	
destruction.
Aim: To	determine	whether	joint	iron	deposition	is	linked	to	clinical	and	imaging	out-
comes	in	order	to	optimize	management	of	haemophilic	joint	disease.
Methods: Adults	with	haemophilia	A	or	haemophilia	B	 (n	=	23,	≥	age	21)	of	all	se-
verities	were	recruited	prospectively	to	undergo	assessment	with	Hemophilia	Joint	
Health	Scores	(HJHS),	pain	scores	(visual	analogue	scale	[VAS])	and	magnetic	reso-
nance	 imaging	 (MRI)	at	3T	using	conventional	MRI	protocols	and	4‐echo	3D‐UTE‐
Cones	sequences	for	one	affected	arthropathic	joint.	MRI	was	scored	blinded	by	two	
musculoskeletal	radiologists	using	the	International	Prophylaxis	Study	Group	(IPSG)	
MRI	scale.	Additionally,	UTE‐T2*	values	of	cartilage	were	quantified.	Correlations	be-
tween	parameters	were	performed	using	Spearman	rank	correlation.	Two	patients	
subsequently	underwent	knee	arthroplasty,	which	permitted	 linking	of	histological	
findings	(including	Perl's	reaction)	with	MRI	results.
Results: MRI	scores	did	not	correlate	with	pain	scores	or	HJHS.	Sixteen	joints	had	
sufficient	cartilage	for	UTE‐T2*	analysis.	T2*	values	for	cartilage	correlated	inversely	
with	HJHS	(rs	=	−0.81,	P	<	0.001)	and	MRI	scores	(rs	=	−0.52,	P	=	0.037).	This	was	
unexpected	since	UTE‐T2*	values	decrease	with	better	joint	status	in	patients	with	
osteoarthritis,	 suggesting	 that	 iron	 was	 present	 and	 responsible	 for	 the	 effects.	
Histological	analysis	of	cartilage	confirmed	iron	deposition	within	chondrocytes,	as-
sociated	with	low	UTE‐T2*	values.
Conclusions: Iron	 accumulation	 can	 occur	 in	 cartilage	 (not	 only	 in	 synovium)	 and	
shows	a	clear	association	with	joint	health.	Cartilage	iron	is	a	novel	biomarker	which,	
if	quantifiable	with	innovative	joint‐specific	MRI	T2*	sequences,	may	guide	treatment	
optimization.
K E Y W O R D S
arthropathy,	cartilage,	haemophilia,	hemophilia	joint	health	score,	hemosiderin,	iron,	magnetic	
resonance	imaging
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1  | INTRODUC TION
Arthropathy	 caused	 by	 frequent	 spontaneous	 joint	 bleeding	 is	 a	
progressive	and	debilitating	co‐morbidity	in	haemophilia.1	The	most	
salient	features	of	haemophilic	arthropathy	are	intra‐	and	periartic-
ular	 soft	 tissue	 inflammation	with	hypertrophy	and	osteochondral	
destruction.2-5	 In	addition	to	insufficient	plasma	clotting	factor	ac-
tivity	levels,	vascular	instability	caused	by	neovascularization,	vessel	
remodelling	and	abnormal	vessel	leakiness	may	fuel	a	vicious	cycle	
of	re‐bleeding,	thereby	promoting	arthropathic	progression.3,6‐8
Supported	by	observations	from	explanted	cartilage	and	hae-
mophilia	mouse	 and	 dog	models,	 the	 concept	 has	 emerged	 that	
iron	released	from	red	cells	and	subsequently	stored	as	hemosid-
erin	 in	 articular	 soft	 tissues	 creates	 a	 ‘toxic’	 environment.9	 As	 a	
consequence,	 dysregulation	 of	 joint	 tissue	 metabolism,	 synovial	
inflammation	 and	 hypertrophy	 occur,	 ultimately	 resulting	 in	 car-
tilage	destruction.5	However,	a	more	exact	understanding	of	the	
influence	of	joint	iron	deposition	on	clinical	outcomes	and	the	pro-
gression	of	arthropathy	in	relation	to	imaging	findings	in	patients	
with	haemophilia	(PWH)	is	lacking.
The	purpose	of	this	study	was	to	evaluate	joints	of	adult	PWH	
using	 conventional	 and	quantitative	ultrashort	 time‐to‐echo	 (UTE)	
magnetic	resonance	 imaging	 (MRI)	sequences	to	delineate	 imaging	
pathology	according	to	IPSG	recommendations,10	which	also	assess	
hemosiderin	content	semi‐quantitatively,	and	to	determine	whether	
findings	correlate	with	Hemophilia	Joint	Health	Scores	(HJHSs)	and	
pain.	 Ultimately,	 we	 felt	 that	 such	 knowledge	would	 improve	 our	
clinical	understanding	of	haemophilic	arthropathy	and	help	to	opti-
mize	the	use	of	clinical	and	radiological	assessments	for	therapeutic	
management.
2  | MATERIAL S AND METHODS
2.1 | Patient population and data extracted
Adult	patients	with	haemophilia	A	or	haemophilia	B	of	all	severi-
ties	 (denoted	as	severe,	moderate	or	mild	depending	on	 intrinsic	
factor	FVIII	or	IX	plasma	activity	of	<1%,	1%‐5%	or	≥5%,	respec-
tively),	 age	 21	 years	 and	 older	 (n	 =	 23),	 and	 seen	 consecutively	
during	 routine	 clinic	 visits	 over	 a	 4‐month	 period,	 underwent	
MRI	examination	of	one	painful	or	uncomfortable	 joint.	At	 inclu-
sion,	Hemophilia	Joint	Health	Scores	(version	2.1)	of	the	affected	
joints11	(HJHS,	0	best,	20	worst)	were	determined	for	the	affected	
joint	by	a	licensed	physical	therapist	with	>5	years	of	general	prac-
tice	experience	and	approximately	2	years	of	experience	with	hae-
mophilia	patients.	The	physical	therapist	was	trained	in	the	HJHS	
acquisition	 according	 to	 instructions	 and	 guidance	 provided	 by	
online	training	and	video	modules	developed	by	the	International	
Prophylaxis	Study	Group	(http://www.ipsg.ca/publi	catio	n/hemop	
hilia‐joint‐health‐score‐instr	uctio	nal‐video‐and‐manual).	Pain	was	
self‐assessed	by	visual	analogue	scale	 (VAS;	0	no	pain;	10	worst	
pain).	In	terms	of	patient	demographics,	only	age,	type	and	severity	
of	haemophilia	were	extracted	from	the	electronic	medical	record.	
The	 study	 protocol,	 data	 acquisition	 and	 patient	 confidentiality	
safeguards	 were	 approved	 by	 the	 Human	 Research	 Protection	
Program	(HRPP)	at	the	University	of	California	San	Diego	(UCSD),	
and	patients	provided	written	informed	consent.
2.2 | MR imaging
MR	imaging	was	performed	on	a	clinical	3T	scanner	(Signa	HDx,	GE	
Healthcare	Technologies)	and	either	an	8‐channel	knee	coil,	4‐chan-
nel	ankle	coil	or	an	8‐channel	flexible	surface	coil	(for	knees,	ankles	
and	elbows,	respectively)	using	the	following	2D	sequences:	sagittal	
fast	spin‐echo	(FSE)	T1‐weighted	(650/10	ms;	echo‐train	length	of	4;	
4	mm	slice	thickness;	0.5	mm	interslice	gap;	384	×	320	matrix;	14	cm	
field	of	view;	and	1	signal	average),	 sagittal	FSE	T2‐weighted	with	
fat	 suppression	 (4000/65	ms;	 echo‐train	 length	of	 12;	 4	mm	 slice	
thickness;	0.3	mm	interslice	gap;	384	×	288	matrix;	14	cm	field	of	
view;	and	2	signal	averages),	coronal	FSE	T1‐weighted	(650/10	ms;	
echo‐train	length	of	4;	4‐mm	slice	thickness,	0.5‐mm	interslice	gap,	
384	×	320	matrix,	14‐cm	field	of	view,	and	2	signal	averages),	coro-
nal	FSE	T2‐weighted	with	fat	suppression	(5000/65	ms,	echo‐train	
length	of	16,	4‐mm	slice	thickness,	0.5‐mm	interslice	gap,	384	×	320	
matrix,	 14‐cm	 field	 of	 view,	 and	 1	 signal	 average),	 axial	 FSE	 T1‐
weighted	(650/10	ms;	echo‐train	length	of	4;	4‐mm	slice	thickness;	
0.5‐mm	interslice	gap;	320	×	288	matrix;	14‐cm	field	of	view;	and	1	
signal	 average)	 and	 axial	 FSE	 intermediate‐weighted	with	 fat	 sup-
pression	(3200/40	ms;	echo‐train	length	of	9;	4‐mm	slice	thickness;	
0.5‐mm	interslice	gap;	320	×	288	matrix;	14‐cm	field	of	view;	and	
1	signal	average).	In	addition,	sagittal	three‐dimensional	(3D)	ultra-
short	echo	time	(UTE)	 images	were	acquired	with	a	cones	readout	
trajectory	at	four	different	echo	times	(TR/TEs,	15	ms/0.03,	2.8‐3,	
5.6‐6	and	8.4‐9	ms;	flip	angle	=	11°;	4	mm	slice	thickness;	256	×	256	
matrix,	14‐cm	field	of	view,	time	~6	minutes).12	Intravenous	contrast	
was	administered	for	select	cases	when	clinically	indicated.
2.3 | Image interpretation and data analysis
The	International	Prophylaxis	Study	Group	(IPSG)	MRI	score10	was	
applied	 by	 a	 fellowship‐trained,	 musculoskeletal	 radiologist	 with	
6	years	of	experience	and	a	 fourth‐year	 radiology	 resident.	Both	
were	blinded	to	each	other's	scores	as	well	as	clinical	scores.	The	
soft	 tissue	 domain,	 composed	 of	 effusion/hemarthrosis,	 synovial	
hypertrophy	and	hemosiderin,	has	a	maximum	score	of	9.	The	os-
teochondral	 domain,	 composed	 of	 surface	 erosions,	 subchondral	
cysts	 and	 cartilage	 degradation,	 has	 a	maximum	 score	 of	 8.	 The	
IPSG	MRI	score	has	a	maximum	combined	score	of	17.	The	pres-
ence	 and	 extent	 of	 hemosiderin	 deposition	 were	 determined	 by	
evaluating	 the	multi‐echo	UTE	 sequence,	with	 special	 considera-
tion	 to	 avoid	misinterpreting	 as	 hemosiderin	 chemical	 shift	 arte-
facts	of	the	second	kind	for	voxels	containing	both	fat	and	water	
on	out‐of‐phase	TEs.13
Using	 the	 sagittal	 multi‐echo	 UTE	 images,	 a	 slice	 extending	
through	 the	 centre	 of	 each	 articulation	was	 selected,	 and	 regions	
of	 interest	 (ROIs)	 were	 carefully	 placed	 on	 the	midportion	 of	 the	
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patellar	and	talar	cartilage	(weight‐bearing	articulations)	on	the	se-
lected	slice.	Most	elbows	exhibited	severe	osteochondral	wear	with	
little	or	no	cartilage	left	for	quantitative	MRI	analysis	and	therefore	
were	excluded	 from	further	analyses.	ROIs	were	selected	 to	mini-
mize	volume	averaging	artefacts.	T2*	values	were	calculated	using	
a	 Levenberg‐Marquardt	 fitting	 algorithm	 developed	 in‐house	 in	
MATLAB	(The	Mathworks	Inc).
2.4 | Human joint tissue and histology
The	harvesting	of	human	tissues	at	the	time	of	total	knee	replace-
ment	surgery	was	approved	by	the	UCSD	HRPP.	To	assess	cartilage	
changes	and	iron	deposition	by	histopathology,	bone	pieces	contain-
ing	articular	cartilage	were	sawed	into	approximately	2	×	1	cm	pieces	
and	fixed	in	formalin	for	>1	week.	Pieces	were	rinsed	and	deminer-
alized	by	daily	changes	of	10%	formic	acid	in	the	presence	of	0.2%	
potassium	ferrocyanide	to	achieve	en	bloc	Perls’	reaction	before	loss	
of	 ferric	 ions	 in	 the	acid	demineralization	 solution.	Decalcification	
included	 5	 days	 of	 formic	 acid,	 followed	 by	 5	 days	 of	 saline	 rins-
ing.	Pieces	of	decalcified	Perls’‐reacted	 tissue	were	 cryoprotected	
in	30%	sucrose	and	cryosectioned	at	8	μm	before	counterstaining	
with	haematoxylin	or	periodic	acid‐Schiff	stain.	To	limit	staining	to	
only	light	red	nuclei	with	haematoxylin,	modified	Harris	haematoxy-
lin	(SH30,	Fisher	Scientific)	was	mixed	1:2	with	0.5%	aqueous	ace-
tic	acid	and	applied	for	only	1	minute	before	differentiation	in	70%	
ethanol	with	1%	HCl.
2.5 | Statistical analysis
Descriptive	 statistics	 were	 used	 to	 describe	 the	 patient	 cohort.	
Correlations	between	cartilage	(T2*)	MRI	findings	with	pain,	HJHS	
and	MRI	IPSG	score	were	achieved	by	Spearman	rank	test.	The	con-
sistency	between	the	two	radiologists	was	evaluated	with	the	intra‐
class	correlation	coefficient.13
3  | RESULTS
3.1 | Patient and joint characteristics
The	cohort	characteristics	are	summarized	in	Table	1.	Briefly,	23	pa-
tients	(median	age	42	years,	standard	deviation	[SDE]	15	years)	were	
recruited	(seven	ankles,	nine	knees,	seven	elbows)	and	imaged	with	
MRI.	There	were	18	patients	with	haemophilia	A	 and	5	with	hae-
mophilia	B.	Only	 four	patients	had	mild	or	moderate	haemophilia;	
the	other	19	patients	had	severe	haemophilia.	MRI	scores	were	very	
similar	between	 the	 two	 readers	and	were	averaged.	There	was	a	
high	degree	of	agreement:	0.95	and	0.98	for	soft	tissue	total	and	os-
seous	total,	respectively.
Mean	HJHS,	VAS	pain	score	and	MRI	IPSG	score	were	5.5	(SDE	
3.4,	range	0‐11),	3.0	(SDE	2.4,	range	0‐7)	and	10.3	(SDE	3.9,	range	
0‐16).	When	 the	 IPSG	MRI	 score	was	divided	 into	 soft	 tissue	 and	
osteochondral	domains,	the	mean	scores	were	3.2	(SDE	2.0,	range	
0‐8)	and	7.0	(SDE	2.4,	range	0‐8),	respectively.
3.2 | Relationships between IPSG MRI scores, 
pain and HJHS
There	 were	 no	 significant	 correlations	 between	 VAS	 pain	 scores	
and	HJHSs	with	 the	MRI	 IPSG	 scores,	 either	 total	 or	 divided	 into	
soft	 tissue	 or	 osteochondral	 sub‐scores.	 Charting	 of	 data	 correla-
tions	revealed	that	advanced	MRI	findings,	represented	as	total	IPSG	
score,	or	subdivided	into	the	osteochondral	and	soft	tissue	domains,	
could	be	present	at	low	HJHSs	already,	or	even	at	a	HJHS	of	zero.	
However,	most	abnormal	MRI	scores	appeared	above	a	HJHS	of	3	
(Figure	1).
3.3 | Quantification of iron in cartilage by MRI T2* 
relaxation and the relation to HJHS
Most	elbows	exhibited	severe	osteochondral	wear	with	little	or	no	
cartilage	 left	 for	quantitative	MRI	analysis.	Therefore,	 iron	quanti-
fication	 in	 cartilage	 was	 only	 performed	 on	 weight‐bearing	 joints	
(knee	 and	 ankles,	 n	 =	 16)	 and	 revealed	 a	wide	 distribution	of	 T2*	
values,	with	a	mean	T2*	relaxation	time	of	9.2	ms	(range	3.0‐14.6	ms)	
(Figure	 2A).	 Strong	 inverse	 correlations	 of	 T2*	 relaxation	 times	
with	HJHSs	(rs	=	−0.81,	P	<	0.001)	and	IPSG	MRI	scores	(rs	=	−0.52,	
P	=	0.037)	were	noted	(Figure	2	B/C),	suggesting	that	iron	was	pre-
sent	in	cartilage	and	that	iron	loading	was	associated	with	a	higher	
degree	 of	 clinical	 and	 imaging‐based	 arthropathic	 joint	 changes.	
When	subdivided	 into	osteochondral	 and	 soft	 tissue	domains,	 the	
TA B L E  1  Patient	and	joint	characteristics
Characteristic  
Patient	(n) 23
Haemophilia	A 18
Haemophilia	B 5
Severity	(n)  
Mild/Moderate 4
Severe 19
Age	(y;	mean	[SDE]) 41.6	(15.2)
Joints	(n)  
Knee 9
Elbow 7
Ankle 7
HJHS	(mean	[SDE]) 5.5	(3.4)
Pain	(VAS	score;	main	[SDE]) 3.4	(2.8)
MRI	IPSG	Score	(mean	[SDE]) 10.3	(3.9)
Soft	tissue	domain 3.2	(1.9)
Osteochondral	domain Modea	=	8
Abbreviations:	HJHS,	Hemophilia	Joint	Health	Score;	IPSG,	
International	Prophylaxis	Study	Group;	MRI,	magnetic	resonance	imag-
ing;	SDE,	standard	deviation;	VAS,	visual	analogue	scale.
aThis	variable	cannot	be	expressed	as	mean	with	SDE	because	of	its	
distribution	with	a	mode	of	8	and	a	range	from	0	to	8.5	(17	subjects	
have	the	same	value	of	8).	
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MRI	soft	tissue	score	also	correlated	negatively	(rs	=	−0.46,	P	=	0.076)	
with	 T2*	 relaxation	 times.	 Correlation	 of	 the	 osteochondral	 MRI	
sub‐score	with	T2*	could	not	be	performed	on	its	own	due	to	ceiling	
effects	of	the	MRI	score,	whereby	10	of	16	MRIs	yielded	the	highest	
score	of	8.	Two	examples,	depicting	iron	quantification	in	the	knee	
joint	of	a	patient	with	severe	haemophilia	A	and	another	patient	with	
mild	haemophilia	A,	are	shown	in	Figure	3.
3.4 | Histological analysis of explanted cartilage for 
iron loading
To	prove	iron	accumulation	in	cartilage	as	suggested	by	MRI,	we	ex-
amined	cartilage	explants,	harvested	subsequently	(within	2	years)	
from	two	of	the	patients	undergoing	total	knee	replacement	surgery.	
The	corresponding	T2*	relaxation	times	in	the	patellae	were	4.1	and	
4.7	ms,	which	were	among	the	lowest	measured,	indicating	high	iron	
loading.	Perls’	reaction	revealed	substantial	iron	deposits	within	the	
cartilage,	mostly	within	and	around	chondrocytes,	but	also	in	lacu-
nae‐like	structures	lacking	any	apparent	active	cell.	Representative	
examples	of	one	patient	are	provided	in	Figure	4.
4  | DISCUSSION AND CONCLUSION
Quantitative	 MRI	 has	 been	 widely	 implemented	 for	 non‐invasive	
evaluation	 of	 hyaline	 articular	 cartilage.14	 Several	 studies	 have	
shown	 that	 chondral	 T2	 and	 T2*	 relaxation	 times	 are	 sensitive	 to	
water	content,	collagen	content	and	collagen	fibril	orientation.15‐17 
Classically,	elevated	T2	values	in	cartilage	have	been	considered	to	
represent	irreversible	damage	to	the	extracellular	matrix.18	Most	re-
cently,	 investigators	 have	 demonstrated	 that	 T2*,	 as	measured	 by	
a	multi‐echo	UTE	technique	similar	 to	 that	used	 in	 this	study,	was	
significantly	 elevated	 in	 cartilage	 of	 injured	 knees	 compared	with	
uninjured	controls.19,20	Based	on	these	results	from	studies	in	non‐
haemophilic	populations	with	injury	or	osteoarthritis,	we	expected	
to	 find	 a	 positive	 correlation	 between	 increasing	 T2*	 relaxation	
times	and	worsening	joint	status.	However,	we	found	a	strong	nega-
tive	correlation	between	joint	status	determined	by	HJHS	and	MRI	
IPSG	scores	with	relaxation	times.	This	seemingly	contradictory	and	
surprising	 result	may	 be	 explained	 by	 our	 histology	 results	 show-
ing	iron	accumulation	in	the	cartilage,	which	would	decrease	T2*.21 
The	strong	negative	correlation	suggests	that	the	T2*	shortening	is	
a	result	of	severe	chondral	iron	deposition	dominating	the	effects.
F I G U R E  1  Relationship	of	HJHS	and	IPSG	MRI	scores.	A,	Total,	B,	
osteochondral	and	C,	soft	tissue	IPSG	MRI	scores	were	plotted	against	
HJHS.	HJHS,	Hemophilia	Joint	Health	Score;	IPSG,	International	
Prophylaxis	Study	Group;	MRI,	magnetic	resonance	imaging
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F I G U R E  2  Quantification	of	iron	in	
cartilage	by	MRI	T2*	relaxation	in	relation	
to	HJHS	and	MRI	scores.	A,	MRI	T2*	
relaxation	times	were	obtained	from	
weight‐bearing	joints	(knees	and	ankles,	
n	=	16),	and	B,	correlated	with	HJHSs	
and	C,	IPSG	MRI	scores	by	Spearman	
rank	test.	HJHS,	Hemophilia	Joint	Health	
Score;	IPSG,	International	Prophylaxis	
Study	Group;	MRI,	magnetic	resonance	
imaging;	rs,	Spearman	rank	correlation	
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F I G U R E  3  Magnetic	resonance	
imaging	quantification	of	iron	in	cartilage	
by	T2*.	Representative	examples	of	A,	
high	cartilage	iron	content	(T2*	=	3)	in	the	
knee	of	a	patient	with	severe	haemophilia	
A	(HJHS	8;	MRI	IPSG	score	10)	and	B,	low	
cartilage	iron	content	(T2*	=	12.1)	in	the	
knee	of	a	patient	with	mild	haemophilia	A	
(HJHS	1;	MRI	IPSG	score	7).	Left	images	
demonstrate	sagittal	multi‐echo	UTE	
images	with	regions	of	interest	drawn	in	
the	midportion	of	the	patella.	Right	images	
demonstrate	excellent	curve	fitting.	HJHS,	
Hemophilia	Joint	Health	Score;	IPSG,	
International	Prophylaxis	Study	Group;	
MRI,	magnetic	resonance	imaging	[Colour	
figure	can	be	viewed	at	wileyonlinelibrary.
com]
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F I G U R E  4  Histological	depiction	
of	iron	accumulation	in	cartilage.	Knee	
cartilage	explants	from	a	patient	with	
haemophilia	and	osteoarthritis	were	
examined	histologically	with	Perls’	
reaction	for	iron	content.	A,	Shows	an	
iron‐rich	region	counterstained	with	
PAS,	showing	association	of	iron	with	
chondron	borders	(25×	objective).	B,	Same	
area	counterstained	for	nuclei	only	with	
red	haematoxylin	on	nearby	section.	C,	
Another	area	of	wide	iron	distribution	
with	red	haematoxylin	counterstain	for	
nuclei	(10×	objective),	with	boxed	region	
shown	in	D	(25×	objective).	Fibrillation	
(arrow)	and	a	paucity	of	chondrocytes	
are	noted	with	many	iron	deposits	(blue	
Perls’	reaction	product)	in	and	around	
chondrocytes	(example	areas	are	denoted	
by	arrow	head).	Bars	20	μm	[Colour	figure	
can	be	viewed	at	wileyonlinelibrary.com]
(A) (B)
(C) (D)
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Iron	deposition	in	chondrocytes	of	deteriorating	cartilage	in	hu-
mans	was	described	decades	ago	in	several	case	series	of	patients	
with	 hemochromatosis.22-24	 However,	 not	 all	 studies	 analysing	 ar-
thritic	joints	of	patients	with	hemochromatosis	have	identified	iron	
in	cartilage	while	synovial	iron	was	readily	detectable.23,25,26	It	has	
been	 suggested	 that	 the	 paucity	 of	 observations	 of	 iron	 in	 carti-
lage	may	be	due	to	the	 lack	of	sensitivity	of	osteochondral	 iron	to	
usual	 iron	 stains	 (such	as	Prussian	blue/Perls’	 stain)	 in	histological	
examinations,	since	iron	particles	are	small	(0.25‐0.5	μ)	and	may	be	
beyond	microscopic	resolution,	or	 to	the	 loss	of	 iron	due	to	acidic	
fixation	 and	 decalcification	 techniques	 of	 joint	 tissue.22	 This	 has	
been	elucidated	by	Ghadially	et	al22	where	iron	detection	with	light	
microscopy	 after	 Prussian	 Blue/Perls’	 staining	 was	 compared	 to	
electron	probe	X‐ray	analysis	of	articular	cartilage	of	 rabbits	after	
induced	 chronic	 hemarthrosis.	 In	 keeping	 with	 this	 observation,	
abundant	 synovial	 hemosiderin	 has	 been	 reported	 in	 haemophilic	
joints,	whereas	cartilage	iron	deposition	has	only	been	described	in	
one	case	by	light	microscopy.27,28To	our	knowledge,	there	is	only	one	
additional	 case	 report,	describing	 iron	accumulation	 in	cartilage	 in	
association	with	chronic	hemarthrosis,	but	without	an	evident	cause	
such	as	haemophilia.29	Taken	together,	it	appears	that	iron	can	accu-
mulate	in	cartilage	with	or	without	hemarthrosis,	but	little	to	nothing	
is	known	about	the	mechanistic	and	molecular	processes	of	cartilage	
iron	loading,	or	its	clinical	consequences.
In	hemochromatosis,	it	has	been	proposed	that	iron	might	con-
tribute	to	the	degeneration	of	cartilage,	but	a	direct	relationship	be-
tween	joint	iron	accumulation	and	degree	of	arthritis	has	not	been	
established.28,30,31
To	date,	 there	 is	no	knowledge	about	 the	extent	of	 iron	accu-
mulation	in	cartilage	of	haemophilic	joints	in	relation	to	joint	status,	
function	or	dynamics	of	joint	deterioration.
Somewhat	 surprisingly,	 observations	 from	 this	 study	 demon-
strated	 that	 there	was	no	 correlation	between	 clinical	 (HJHS)	 and	
imaging	(MRI)	scores,	with	highly	abnormal	imaging	findings	present	
over	a	wide	spectrum	of	clinical	scores.	Similarly,	widely	divergent	
and	mostly	poor	correlations	between	MRI	 IPSG	scores	and	HJHS	
were	reported	previously,32-34	especially	in	relation	to	the	soft	tissue	
compartments,32	possibly	dependent	on	joint	type	and	articulations	
involved.34	These	findings	suggest	that,	while	depicting	joint	dete-
rioration,	imaging	abnormalities	may	have	limited	bearing	on	clinical	
joint	status,	which	may	be	driven	at	least	in	part	by	individual	pain	
perception	 and	 functional	 mobility.	 In	 aggregate,	 these	 observa-
tions	corroborate	 that	 the	severity	of	 imaging	 findings	can	be	dis-
sociated	from	clinical/functional	 joint	status	as	has	been	observed	
in	other	arthritic	conditions.35	However,	when	imaging	was	focused	
on	chemical	iron	quantification	using	T2*	relaxation,	significant	cor-
relations	between	iron	content	and	clinical	scores	as	well	as	imaging	
scores	became	evident.	Reasons	are	unclear,	but	also	indicate	that	
both	 are	 affected	 proportionally	 by	 cartilage	 iron	 loading.	 These	
findings	suggest	that	(a)	iron	accumulation	in	association	with	joint	
bleeding	occurs	in	cartilage	and	not	solely	in	synovial	tissue	as	pre-
viously	believed	and	(b)	that	 iron,	once	deposited	 in	cartilage,	may	
play	 an	 important	 role	 for	 direct	 and	 continued	 cartilage	 toxicity,	
destruction	and	the	progression	of	haemophilic	arthropathy.	This	is	
of	 importance	since	osteochondral	changes	in	haemophilia	are	be-
lieved	to	be	mediated	more	indirectly	by	the	pro‐inflammatory	mi-
lieu	created	by	iron	in	synovial	fluid	and	the	synovium5,36	rather	than	
by	direct	deposition	of	iron	in	cartilage.	In	that	sense,	the	pathways	
of	iron	uptake	into	cartilage	and	iron	retention,	potentially	causing	
damage	from	‘inside‐out’	rather	than	from	‘outside‐in’,	as	well	as	the	
potential	for	reversibility	of	cartilage	iron	loading	are	unknown.
These	findings	suggest	a	need	not	only	to	study	molecular	path-
ways	of	cartilage	iron	loading	and	retention,	but	also	to	develop	and	
validate	sensitive	MRI	iron	quantification	methodologies	specific	to	
cartilage	or	other	 joint	tissues	for	more	 immediate	clinical	applica-
tion.	A	number	of	novel	quantitative	MRI	techniques	are	 in	devel-
opment	 37,38	which,	 if	 adjusted	 for	 cartilage	 imaging,	may	 provide	
sensitive	methods	to	precisely	quantify	cumulative	joint	iron	loading	
over	time.	Quantitative	iron	imaging	would	revolutionize	the	ability	
to	recognize	the	consequences	of	subclinical	bleeding	and/or	subop-
timal	 treatment	strategies	 in	haemophilia.	At	present,	hemosiderin	
quantification	 is	 only	 possible	 in	 a	 semi‐quantitative	 fashion,10,32 
which	lacks	sensitivity	for	dynamic,	incremental	measurements.
MRI	T2*	has	been	performed	previously	 to	quantify	 iron	 load-
ing	of	solid	organs	(liver	and	heart)	 in	iron	overload	disorders	such	
as	 hemochromatosis,	 hemoglobinopathies	 or	 other	 conditions	 of	
transfusion	iron	overload,39,40	but	has	not	been	validated	yet	for	iron	
loading	of	joint	tissues.	While	our	results	strongly	suggest	that	T2*	
imaging	can	detect	cartilage	iron,	sequences	will	have	to	be	adjusted,	
improved	and	validated	for	joints.	The	development	of	such	appro-
priate	T2*	joint	imaging	sequences	may	come	timely	since	the	man-
agement	 of	 haemophilia	 is	 currently	 undergoing	 a	 paradigm	 shift.	
Traditionally,	the	reduction	of	symptomatic	joint	bleeding,	often	ex-
pressed	as	annual	bleeding	rate	(ABR),	has	been	the	most	important	
outcome	parameter	for	clotting	factor	therapies.	However,	ABR	may	
be	insufficient	to	guide	management	decisions	for	(a)	emerging	non‐
factor	therapies,	such	as	the	recently	FDA‐approved	FVIII‐mimetic	
emicizumab	(Hemlibra®,	Genentech)	improving	coagulation	profiles	
and	 (b)	 gene	 therapies	 on	 the	 horizon	 with	 anticipated	 constant	
elevation	 of	 plasma	 factor	 activity	 levels.41	 Since	 these	 new	 ther-
apies	mitigate	 or	 abrogate	 the	 fluctuations	 between	 plasma	 peak	
and	 trough	 clotting	 factor	 activity	 levels,	 correction	 of	 subclinical	
bleeding	 (rather	 than	 overt	 clinical	 bleeding)	 and	 appropriate	 iron	
clearance	from	the	joint	is	important.	It	is	in	this	arena	that	hemosid-
erin	quantitation	in	joints	could	become	a	valuable	assessment	tool	
to	measure	 treatment	 success.	 In	 that	 sense,	 interval	detection	of	
accumulation	of	hemosiderin	during	long‐term	treatment	plans,	em-
ploying	non‐factor	or	clotting	factor	strategies,	would	indicate	that	
the	prescribed	therapy	may	not	be	adequate.	Optimization	of	ther-
apy	may	be	achieved	by	discussing	improved	compliance,	switching	
strategies,	 and/or	 adjustments	with	 respect	 to	 dosing	 and/or	 fre-
quency	of	drug	administration.
In	summary,	it	appears	important	to	recognize	that	hemosiderin	
accumulation	occurs	 not	 only	 in	 synovium,	 but	 also	 in	 cartilage,	 a	
fact	 that	 may	 be	 generally	 underappreciated	 in	 haemophilia	 care	
due	to	difficult	histological	detection	by	conventional	 iron	staining	
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methods.	 Since	 findings	 from	our	 study	 revealed	 that	 the	 amount	
of	 cartilage	 iron	 is	 associated	with	deteriorating	clinical	 and	 imag-
ing	joint	status,	we	hypothesize	that	cartilage	iron	plays	a	significant	
role	 in	the	progression	of	haemophilic	arthropathy.	Therefore,	car-
tilage	iron	could	be	considered	a	biomarker	of	joint	health	that	may	
become	directly	quantifiable	with	innovative	joint‐specific	MRI	T2*	
sequences,	thus	guiding	the	adjustment	of	therapeutic	strategies	to	
optimize	joint	health	in	patients	with	haemophilia.
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